Melissa R. Band

https://assets.montefioreeinstein.org/profiles/images/Band_Melissa_DO_2x.jpg

First Name

Melissa

Last Name

Band

NPI

1326542655

Faculty ID

17899

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

187865

Visit Type ID

2528

Is Open Scheduling

On

Shudan Wang

https://assets.montefioreeinstein.org/profiles/images/physphoto/Wang_Shudan_420x504.jpg

First Name

Shudan

Last Name

Wang

NPI

1831432780

Faculty ID

15876

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; text-indent: .5in; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman';">Dr. Wang is an Attending Physician in the Division of Rheumatology at Montefiore Medical Center, and an Assistant Professor of Medicine at Albert Einstein College of Medicine. She is board certified in both internal medicine and rheumatology and currently sees patients at the Montefiore Westchester Practice at Taxter Road. Dr. Wang has an expertise in lupus and lupus related kidney disease. She is also skilled to see a wide range of other rheumatologic diseases, including but not limited to antiphospholipid syndrome, Sjogren&rsquo;s syndrome, rheumatoid arthritis, <span style="color: black;">spondyloarthropathy</span>&nbsp;and psoriatic arthritis, vasculitis, myositis, polymyalgia rheumatica, scleroderma and osteoarthritis.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; text-indent: .5in; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman';">Dr. Wang graduated from McGill University with a major in Physiology and Statistics in 2009. Dr. Wang received her medical degree from Rutgers New Jersey Medical School in 2013. She subsequently completed her internal medicine residency training at New York Presbyterian Hospital Cornell in 2016, followed by a fellowship in Rheumatology at New York University Hospital in 2018. Dr. Wang obtained a MS in clinical research from the Albert Einstein Clinical Research Training Program in 2021. </span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; text-indent: .5in; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman';">Dr. Wang's research interest is in lupus, focused on the role of the complement system in lupus related kidney disease. Dr. Wang is supported by the NIH KL2 Mentored Clinical Research Scholar Grant and the Rheumatology Research Foundation K-Bridge Grant to investigate complement biomarkers in lupus nephritis using various translational approaches including immunohistochemistry, urine proteomics and single cell RNA sequencing. Dr. Wang has experience working with large cohorts and databases, recruiting patients for the Einstein Rheumatic Disease Registry and serve as sub-investigator for lupus clinical trials. She has published first author papers in prestigious journals, presented her academic work at national meetings and served on NIH and CDC study sections. She was recognized by American College of Rheumatology as a Distinguished Fellow nationally for translational research and clinical excellence in 2018.</span></p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="mso-outline-level: 1;"><strong><span style="font-family: 'Arial',sans-serif;">Wang Shudan</span></strong><span style="font-family: 'Arial',sans-serif;">, Wu M, Chiriboga L, Zeck B, Goilav B, Wang Shuwei, Jimenez-Londono A, </span><span style="font-family: 'Arial',sans-serif;">Putterman C, Schwartz D, Pullman J, Broder A, HM Belmont. Membrane Attack Complex (MAC) Deposition in Renal Tubules is Associated with Interstitial Fibrosis/Tubular Atrophy: A Pilot Study. <em>Lupus Science &amp; Medicine. </em>2022 Jan; 9(1). </span></p>
<p class="MsoNormal" style="mso-outline-level: 1;"><span style="font-family: 'Arial',sans-serif;">Tagoe, CE, Wang W, <strong>Wang S</strong>, Barbour K. Association of anti-thyroid antibodies with radiographic knee osteoarthritis and chondrocalcinosis: a NHANES III study. <em>Therapeutic Advances in Musculoskeletal Disease. </em>2021 Aug 4; 13. </span></p>
<p class="MsoNormal" style="mso-outline-level: 1;"><span style="font-family: 'Arial',sans-serif;">Guerrero, MS, Londono, A, Dobrowolski C, Mowrey WB, Goilav B, <strong>Wang S</strong>, Broder A. Systemic Lupus Erythematosus Activity and Hydroxychloroquine Use Before and After End-Stage Renal Disease. <em>BMC Nephrology</em>. 2020 Oct 28; 21(1): 450.</span></p>
<p class="MsoNormal"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Arial',sans-serif;">Wang S, </span></strong><span style="font-family: 'Arial',sans-serif;">Wu M, Pillinger MH, Krasnokutsky, S, and Barbour K. The Association between Asymptomatic Hyperuricemia and Knee Osteoarthritis: Data from Third National Health and Nutrition Examination Survey. <a title="Osteoarthritis and cartilage." href="https://www.ncbi.nlm.nih.gov/pubmed/?term=The+Association+between+Asymp… class="highlight"><em><span style="color: windowtext; text-decoration: none; text-underline: none;">Osteoarthritis</span></em></span><em> Cartilage.</em></a> 2019 Sep;27(9):1301-1308. </span></p>
<p class="MsoNormal"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Arial',sans-serif; color: black;">Wang S, </span></strong><span style="font-family: 'Arial',sans-serif; color: black;">Wu M, Chiriboga L, Zeck B, HM Belmont. Membrane Attack Complex (MAC) Deposition in Lupus Nephritis is Associated with Hypertension and Poor Clinical Response to Treatment. <em style="mso-bidi-font-style: normal;">Semin Arthritis Rheum. 2018; 48(2): 256-262.</em><span style="mso-spacerun: yes;">&nbsp; </span></span></p>
<p class="MsoNormal"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Arial',sans-serif; color: black;">Wang S, </span></strong><span style="font-family: 'Arial',sans-serif; color: black;">Broder N, Marchetta P, Nowatzky J. Myelodysplastic syndrome presenting as a Behcet&rsquo;s like syndrome with aortitis. <em style="mso-bidi-font-style: normal;">BMJ Case Rep. 2018 March 15. </em><span style="mso-spacerun: yes;">&nbsp;</span></span></p>
<p class="MsoNormal"><span style="font-family: 'Arial',sans-serif; color: black;">Oshima-Takane Y, <strong style="mso-bidi-font-weight: normal;">Wang S</strong>, Takane M and Takane, Y. T</span><span style="font-family: 'Arial',sans-serif;">he Acquisition of Personal Pronouns in English: Neural Network Stimulations. S<em style="mso-bidi-font-style: normal;">tudies in Language Sciences. 2014, Jan: 13 (53-69).</em></span></p>
<p class="MsoNormal" style="margin-right: 24.0pt;"><span style="font-family: 'Arial',sans-serif;">Sleat DE, Ding L, <strong style="mso-bidi-font-weight: normal;">Wang S, </strong>Zhao C, Wang Y, Zheng H, Moore DF, Sims KB, Lobel P<strong style="mso-bidi-font-weight: normal;">. </strong>Mass spectrometry-based protein profiling to determine the cause of lysosomal storage disease of unknown etiology. <em style="mso-bidi-font-style: normal;">Mole Cell Proteomics</em>. <em style="mso-bidi-font-style: normal;">2009 Jul; 8(7): 1708-18.</em> </span></p>
<p class="MsoNormal" style="margin-right: 24.0pt; text-indent: -.25in;"><strong style="mso-bidi-font-weight: normal;"><span style="mso-bidi-font-family: Arial;">&nbsp;</span></strong></p>

EMR ID

13915

Visit Type ID

2528

Is Open Scheduling

On

Zocdoc Link

Clement E. Tagoe

https://assets.montefioreeinstein.org/profiles/images/physphoto/Tagoe_Clement_MD_420x504.jpg

First Name

Clement

Last Name

Tagoe

NPI

1801985197

Faculty ID

9904

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Clement Tagoe obtained his medical degree from the University of Ghana Medical School, Ghana, and a PhD in biochemistry from the University of Leeds, UK. His basic science research interests included the study of the role of annexins in cell function and rheumatic diseases, and subsequently the mechanisms of disease in transthyretin amyloidosis using several animal models of transthyretin amyloidosis. His clinical work in the area of transthyretin amyloidosis has greatly illuminated our understanding of the form of amyloidosis associated with the Transthyretin V122I (pV142I) mutation, which is found in about 3 to 4% of African Americans. His current work focuses on the role of autoimmune diseases in fibromyalgia and chronic widespread pain, and in particular the association of these syndromes with autoimmune thyroid disease (AITD). His work also explores the other musculoskeletal and rheumatic manifestations of autoimmune thyroid disease, including the association with peripheral osteoarthritis and spinal osteoarthritis. These autoimmune syndromes can occur in the absence of thyroid dysfunction and are of particular interest to physicians and patients because AITD is by far the commonest autoimmune disease.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p class="MsoNormal"><strong>Selected Bibliography</strong></p>
<p class="MsoNormal">1. Clement E. Tagoe, Tejas Sheth, Eugeniya Golub, Karen Sorensen (2019) Rheumatic associations of autoimmune thyroid disease: a systematic review Clin Rheumatol. 2019 Jul;38(7):1801-1809., (1-9) DOI:&nbsp; 10.1007/s10067-019-04498-1</p>
<p class="MsoNormal">2. Kavisha Patel, Clement Tagoe, Phyllis Bieri, Karen Weidenheim &amp; James M. Tauras (2018): A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G &gt; T, p.Ala140Ser), Amyloid, DOI: 10.1080/13506129.2018.1491398</p>
<p class="MsoNormal">3. Daniel R. Jacobson, Alice A. Alexander, Clement Tagoe, W. Timothy Garvey, Scott M.</p>
<p class="MsoNormal">Williams, Sara Tishkoff, David Modiano, Sodiomon Bienvenu Sirima, Issa Kalidi, Toure A, &amp; Joel N. Buxbaum. The Prevalence and Distribution of the Amyloidogenic Transthyretin (TTR) V122I Allele in Africa&nbsp; Molecular Genetics &amp; Genomic Medicine Epub 14 July, 2016&nbsp; DOI: 10.1002/mgg3.231</p>
<p class="MsoNormal">4. Asha Shrestha, Hillel W. Cohen, Clement E. Tagoe. Association of Autoimmune Thyroid Disease With A Higher Frequency Of Spinal Degenerative Disc Disease Clin Exp Rheumatol. 2016 Mar-Apr;34(2):296-302. Epub 2016 Feb 9. PMID: 26885680</p>
<p class="MsoNormal">5. Tagoe CE, Zezon A, Khattri S. Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease. J Rheumatol. 2012 Jun;39(6):1125-9. Epub 2012 Apr 15.</p>
<p>&nbsp;</p>
<p class="MsoNormal">&nbsp;</p>
<p>&nbsp;</p>

EMR ID

4680

Visit Type ID

2528

Is Open Scheduling

On

Chaim Putterman

https://assets.montefioreeinstein.org/profiles/images/physphoto/Putterman_Chaim_MD_420x504.jpg

First Name

Chaim

Last Name

Putterman

NPI

1992894281

Faculty ID

6386

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span style="font-size: large;"><strong>Chaim Putterman, MD - Summary of Research Program and Goals</strong></span></p>
<p>&nbsp;&nbsp;&nbsp;Systemic lupus erythematosus (SLE) is a prototypical systemic autoimmune disease,&nbsp; characterized by the presence of numerous autoantibodies and involvement of multiple organ systems. Inflammation of the kidneys, or lupus nephritis, appears in up to 50% of lupus patients during the course of their disease. Despite medical treatment, morbidity and mortality from renal disease are all too common in lupus patients, with reports of 5-year renal survival ranging from 46-95%. Overall increases in the incidence of lupus and in the number of deaths from the disease reported in the United States are additional reasons for significant concern for clinicians and researchers alike. Unfortunately, major strides forward in understanding lupus and the advent of newer "biologic" therapies in the field of Rheumatology have yet to translate into measurable benefits for the majority of patients with SLE. Current treatments, while effective, only control disease activity but are not curative. Furthermore, therapeutic modalities that are employed at this time for the treatment of patients with lupus are non-specific - and commonly affect normal cells that are essential for the defense against foreign pathogens, in addition to suppressing the disease-relevant autoreactive B cells. Nevertheless, early diagnosis and prompt treatment can still significantly improve long-term prognosis.<br /> &nbsp;<br /> &nbsp;&nbsp; Anti-double stranded (ds) DNA antibodies are a serologic hallmark of patients with SLE. In recent years it has been increasingly clear that not only are anti-dsDNA antibodies an important diagnostic marker for lupus, but that these autoantibodies are also instrumental in the pathogenesis of lupus nephritis. The mechanisms by which anti-dsDNA antibodies induce renal injury, however, are not completely understood. It has been suggested that anti-dsDNA antibodies bind DNA in the circulation followed by non-specific deposition of these immune complexes in the kidney, or that in-situ immune complexes are formed in the kidney by binding of anti-dsDNA antibodies to nuclear antigens deposited on the glomerular basement membrane. Alternatively, some anti-dsDNA antibodies may cause injury by penetrating into living cells and affecting metabolic pathways. Finally, we and others have generated evidence that strongly suggests that at least some anti-dsDNA antibodies are pathogenic not by virtue of their affinity for DNA, but rather by direct cross-reactivity with renal antigen.<br /> &nbsp;<br /> &nbsp;&nbsp; One major long-term goal of the laboratory is to study the renal pathogenicity of anti-dsDNA antibodies. We are determining the cross-reactive kidney antigen bound by anti-DNA antibodies in human lupus and in mouse models of the disease to understand what determines the nephritogenic potential of these antibodies. We made significant progress in defining one renal antigen bound by cross-reactive anti-DNA antibodies. We discovered that a-actinin is a major cross-reactive target for the anti-dsDNA antibody response in murine lupus, and that both human monoclonal and polyclonal anti-dsDNA antibodies bind to a-actinin as well. In current studies, we are investigating if a-actinin can serve not only as a target but also as an antigenic trigger for anti-DNA antibodies, whether anti-a-actinin antibodies are associated with specific disease features (analysis of patient cohorts), and what might be the mechanism by which these antibodies induce damage in kidney cells (proteomic and microarray approaches). Understanding the renal pathogenicity of cross-reactive anti-dsDNA antibodies by identifying the target antigen for these antibodies in the kidney would improve our understanding of a key manifestation of lupus, and would facilitate the development of serological tools to better predict the onset and severity of renal involvement in patients with SLE. Furthermore, identification of the triggering and/or target antigen in lupus will allow us to develop novel approaches to the treatment of lupus, by blocking the effects of anti-DNA antibodies on target organs or by specifically tolerizing pathogenic B cells.<br /> &nbsp;<br /> &nbsp;&nbsp; Members of the TNF-superfamily of ligands are centrally involved in normal immune responses, and in the pathogenesis of autoimmune disorders. In a second group of related projects in the laboratory, we are investigating the role of a relatively new member of the TNF superfamily (TWEAK) and its receptor Fn14 in the pathogenesis of lupus, specifically lupus nephritis. We have shown that TWEAK induces a pro-inflammatory profile of cytokines and chemokines in kidney epithelial and mesangial cells, and thus contributes to the influx of inflammatory cells observed in the early stages of lupus nephritis. Modulation of the TWEAK/Fn14 pathway in SLE may be an important target for novel therapies for this disease. Furthermore, we are exploring the role of TWEAK as a biomarker for disease activity in lupus nephritis. Indeed, such as serum or urinary biomarker would have tremendous value for patient care, allowing early and accurate diagnosis and more precise management, without the need for an invasive kidney biopsy.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

PubMed.gov URL

Selected Publications

<div><span style="text-decoration: underline;"><br /></span></div>
<p>&nbsp;</p>

EMR ID

4073

Is Open Scheduling

Off

Konstantinos Loupasakis

https://assets.montefioreeinstein.org/profiles/images/physphoto/Loupasakis_Konstantinos_MD_420x504.jpg

First Name

Konstantinos

Last Name

Loupasakis

NPI

1194954602

Faculty ID

16964

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

141706

Biography

<p>Konstantinos Loupasakis, MD, is an attending rheumatologist at Montefiore Einstein and Rheumatology Fellowship Program Director and Associate Professor, Medicine at our Albert Einstein College of Medicine. Dr. Loupasakis sees patients with a wide range of rheumatologic diseases including rheumatoid arthritis, systemic lupus and multisystem sarcoidosis.</p><p>In 2007, Dr. Loupasakis earned his medical doctorate at University of Crete in Greece. He later came to the United States to further his medical training, completing his medical residency at Steward St. Elizabeth&rsquo;s Medical Center, Tufts University School of Medicine in 2012, followed by his rheumatology fellowship at Hospital for Special Surgery, Weill Cornell Medical College of Cornell University in 2015 and a yearlong research fellowship at the same institution in 2016.</p><p>Dr. Loupasakis' research focus includes multisystem sarcoidosis, lupus, rheumatoid arthritis and medical education. He is a certified facilitator, teaching relationship-centered communication in healthcare, and is particularly interested in optimization of the patient-physician relationship. Dr. Loupasakis has shared his work through peer-reviewed journals, abstracts, poster presentations and invited national and regional presentations. He is also a reviewer for scientific rheumatology journals.</p><p>Dr. Loupasakis is board certified in Rheumatology by the American Board of Internal Medicine. He is a member of the American College of Rheumatology. Dr. Loupasakis has been twice recognized at Montefiore Einstein for his outstanding service and teaching, receiving an award in 2022 for his inpatient consult service and in 2024 for his outpatient service.</p>

Visit Type ID

2528

Is Open Scheduling

On

Jeanie Lee

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/cbb45e50-f88f-11ec-9cb7-15f799598473.jpg

First Name

Jeanie

Last Name

Lee

NPI

1487040861

Faculty ID

17122

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="p1" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: 'Open Sans', sans-serif;">Jeanie Lee, MD is a clinician educator and Assistant Professor of Medicine (Rheumatology). Dr.&nbsp;Lee&nbsp;graduated from CUNY Brooklyn College through the combined BA-MD program and earned her medical degree at SUNY Downstate. She then completed her Internal Medicine residency at Zucker School of Medicine-Northwell Health, where she also served as chief resident, and her Rheumatology fellowship at Einstein/Montefiore. She joined Einstein/Montefiore as faculty in 2021.<span class="apple-converted-space">&nbsp;</span></span></p>
<p class="p1" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;">&nbsp;</p>
<p class="p1" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: 'Open Sans', sans-serif;">Dr. Lee&rsquo;s clinical interests are centered on cutaneous manifestations of rheumatic disease. She co-founded and co-directs the Rheumatology-Dermatology Combined Clinic located in Elmsford, NY. Dr. Lee is also skilled in musculoskeletal ultrasound and certified by Ultrasound School of North American Rheumatologists (USSONAR).</span></p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

111635

Biography

<p>Jeanie Lee, MD, is Co-Director, Rheumatology-Dermatology Combined Clinic (RDCC) and Attending Rheumatologist at Montefiore Einstein and Assistant Professor, Medicine at our Albert Einstein College of Medicine. Dr. Lee&rsquo;s clinical interests are centered on skin conditions associated with rheumatic disease. She is also skilled in musculoskeletal ultrasound.</p><p>After earning her Bachelor of Science in biology as part of the BA-MD medical program at CUNY Brooklyn College in 2011, Dr. Lee completed her Doctor of Medicine at State University of New York Downstate College of Medicine in 2015. She completed her internal medicine residency at Zucker School of Medicine at Hofstra/Northwell in 2019, taking on the role of Chief Resident in her final year. She then came to Montefiore Einstein to pursue her rheumatology fellowship, completing it in 2021.</p><p>Dr. Lee's research focuses on identifying the clinical, serological, and histopathological features of patients with disease that have rheumatology and dermatology overlap. She has shared her work through peer-reviewed journals, book chapters, abstracts and invited presentations.</p><p>Dr. Lee is board certified in Internal Medicine and Rheumatology by the American Board of Internal Medicine, and is certified by the Ultrasound School of North American Rheumatologists. She is a member of the American College of Physicians, the American College of Rheumatology and the Alpha Omega Alpha Honor Medical Society.</p>

Visit Type ID

2528

Is Open Scheduling

On

Zocdoc Link

Anand A. Kumthekar

https://assets.montefioreeinstein.org/profiles/images/physphoto/Kumthekar_Anand_MD_420x504.jpg

First Name

Anand

Last Name

Kumthekar

NPI

1962843391

Faculty ID

15815

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="p1" style="margin: 0px 0px 12px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 16px; line-height: normal; font-family: Arial; -webkit-text-stroke-color: #000000;"><span class="s1" style="font-kerning: none;">Dr. Kumthekar is board certified in Internal Medicine and Rheumatology. He received his medical degree from Pravara Institute of Medical Sciences, India and trained in Internal Medicine at Jacobi Medical Center/Albert Einstein College of Medicine. He further completed his sub-specialty training in Rheumatology at Oregon Health and Science University.</span></p>
<p class="p1" style="margin: 0px 0px 12px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 16px; line-height: normal; font-family: Arial; -webkit-text-stroke-color: #000000;"><span class="s1" style="font-kerning: none;">Dr. Kumthekar is an Assistant Professor of Medicine at Albert Einstein College of Medicine and an attending physician at Montefiore Medical Center. He is skilled in the treatment of general rheumatic illness and h</span>is clinical areas of focus include Ankylosing Spondylitis, Psoriatic arthritis, Rheumatoid arthritis, &nbsp;Vasculitis, Lupus and Myositis. He runs the Spondyloarthritis clinic at Montefiore and is profecient in musculoskeletal ultrasound. He has published multiple research articles and is a reviewer/editorial board member prominent medical journals.He has completed advanced MSK ultrasound training and is certified by the American College of Rheumatology (RhMSUS). He is a member of American College of Rheumatology, Spondyloarthritis Research and Treatment Network (SPARTAN), Group for Research and Assessment of. Psoriasis and Psoriatic Arthritis (GRAPPA) and Ultrasound School of North American Rheumatologists (USSONAR).</p>
<p class="p1" style="margin: 0px 0px 12px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 16px; line-height: normal; font-family: Arial; -webkit-text-stroke-color: #000000;">&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*&nbsp;</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Stienstra N, Horton J, Lane M, <strong>Kumthekar A,</strong> Sathe N, Sunny C, Yadav V, Deodhar A. Demyelinating Disease After Exposure to Tumor Necrosis Factor &alpha; Inhibitors: A Case Series in a Tertiary Care Center. JCR: Journal of Clinical Rheumatology. 2022 Mar 1;28(2):e638-41.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*&nbsp;</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Patel S,&nbsp;<strong>Kumthekar A</strong>. Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice. Rheumatology and Therapy. 2021 Nov 19:1-23.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*&nbsp;</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Bittar M, Dubreuil M. Educational needs and challenges in axial spondyloarthritis. Current Opinion in Rheumatology. 2021 Jul 1;33(4):313-8.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Kaur N, <strong>Kumthekar A</strong>, Ayesha B. When sarcoidosis mimics immunodeficiency. BMJ Case Reports CP. 2021 Jul 1;14(7):e243557.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Patel S, Bibi A, Eisenberg R, Gendlina I, Murakhovskaya I, Ramesh M, Balagula Y, <strong>Kumthekar A</strong>. The Role of Early Subspeciality Consultation in the Timing of Hemophagocytic Lymphohistiocytosis Diagnosis and Management. Journal of clinical rheumatology: practical reports on rheumatic &amp; musculoskeletal diseases. 2021 Jun 18.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*&nbsp;</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Cui Z, Merritt Z, Assa A, Mustehsan H, Chung E, Liu S, <strong>Kumthekar A,</strong> Ayesha B, McCort M, Palaiodimos L, Baron S. Early and Significant Reduction in C-Reactive Protein Levels After Corticosteroid Therapy Is Associated With Reduced Mortality in Patients With COVID-19. Journal of Hospital Medicine. 2021 Feb 17.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">*&nbsp;</span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Ayesha B,<strong> Kumthekar A</strong>, Jain R, Patel S, Ramesh M, Ferastraoaru DE, Hudes G, Karagic M, Zafar S, Bartash R, Vasquez‐Canizares N. Rapid Implementation of a Multidisciplinary COVID‐19 Cytokine Storm Syndrome Task Force. ACR Open Rheumatology. 2021 Feb 6.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>*&nbsp;</strong></span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Deodhar A. Axial Spondyloarthritis and Ankylosing Spondylitis. Physician Assistant Clinics.;6(1):135-47.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>* Kumthekar A,</strong> Ogdie A. Obesity and Psoriatic Arthritis: A Narrative Review. Rheumatology and Therapy. 2020 Jun 3.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* Abbi B, Patel S, <strong>Kumthekar A</strong>, Schwartz D, Blanco I. A Case of Cardiomyopathy With Long-term Hydroxychloroquine Use. JCR: Journal of Clinical Rheumatology. 2020 May 9.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Park SS, Akella S, <strong>Kumthekar A</strong>, Barmettler A. Extrapulmonary Sarcoidosis in the Orbit, Brain, and Heart. The American journal of medicine. 2019 Dec 17.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Shull S, Lovejoy TI, Morasco BJ, Chang M, Barton J. Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis. International journal of rheumatic diseases. 2019 Apr;22(4):592-8.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Raess PW, Ghetie D. A Missing Link: Sarcoid-Lymphoma Syndrome. The American Journal of Medicine. 2019 Jan 1;132(1):48-51.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Horton J, <strong>Kumthekar A.</strong> A Vanishing Entity: Rheumatoid Vasculitis. The American Journal of Medicine. 2018 Nov 1;131(11):1310-3.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Wolf B, Woltjer R, Schwab P. More than meets the eye: a case of HCV-induced PAN. Modern Rheumatology Case Reports. 2018 Jul 3;2(2):199-203.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Danve A, Deodhar A. Use of belimumab throughout 2 consecutive pregnancies in a patient with systemic lupus erythematosus. The Journal of Rheumatology. 2017 Sep 1;44(9):1416-7.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Deodhar A, <strong>Kumthekar A,</strong> Dubreuil M. Minimal disease activity in axial spondyloarthritis: the need of the hour and a proposal for development. Current opinion in rheumatology. 2017 Jul;29(4):293.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Akenroye AT, <strong>Kumthekar AA</strong>, Alevizos MK, Mowrey WB, Broder A. Implementing an electronic medical record&ndash;based reminder for cardiovascular risk screening in rheumatoid arthritis. Arthritis Care &amp; Research. 2017 May;69(5):625-32.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Palkar P, <strong>Kumthekar A</strong>. Comment on: Dance-like movements in obsessive compulsive disorder. Indian journal of psychological medicine. 2017 May 1;39(3).</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">*&nbsp; </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Johnson B. Polyarticular severe tophaceous gout secondary to limited medication access. The Journal of rheumatology. 2015 Aug 1;42(8):1528-9.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Palkar PY, <strong>Kumthekar AA.</strong> Roar of meow-meow (mephedrone) in India. Journal of Mental Health and Human Behaviour. 2015 Jul 1;20(2):55.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar A</strong>, Cossarini F, Shih JC, Taub CC, Massera D. Ranolazine-induced repolarization changes: a case report. The American Journal of Medicine. 2015 Jul 1;128(7):e3-5.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">* </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;"><strong>Kumthekar AA</strong>, Gidwani HV, Kumthekar AB. Metformin associated B12 deficiency. J Assoc Physicians India. 2012 Mar 1;60(3):58-9.</span></p>
<p><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">*&nbsp; </span><span style="color: #222222; font-family: Arial, sans-serif; font-size: 13px;">Hitesh Vinod C, Misra BN, <strong>Kumthekar AA</strong>, Kawatra A. CALIBRATION AND CUFFING ISSUES CONCERNING SPHYGMOMANOMETER&rsquo;S IN A TERTIARY HEALTH CARE CENTRE. Indian J. Prev. Soc. Med. 2013 Jul;44(3-4):166.</span></p>

EMR ID

56458

Visit Type ID

2528

Is Open Scheduling

On

Zocdoc Link

Elizabeth A. Kitsis

https://assets.montefioreeinstein.org/profiles/images/elizabeth-kitsis.jpg

First Name

Elizabeth

Last Name

Kitsis

NPI

1174692040

Faculty ID

11563

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Elizabeth Kitsis is the Senior Associate Dean for Faculty Affairs and Strategic Planning at Einstein. In this role, she supports the Einstein faculty in all aspects of professional development and well-being. She oversees faculty appointments and promotions, annual faculty evaluations, and faculty mentoring, among other activities. In addition, she leads the strategic planning process for Einstein.</p>
<p>In addition to her role in the Dean's Office, Dr. Kitsis is a rheumatologist with an interest in bioethics. After earning an MD from Cornell University Medical College, she completed her internal medicine residency at Boston City Hospital and rheumatology fellowship at New York University Medical Center, where she was also chief fellow. While on the faculty at NYU, Dr. Kitsis was Director of Clinical Research in Rheumatology.</p>
<p>Dr. Kitsis worked in the pharmaceutical industry for a decade, holding several roles at Pfizer Inc., including Vice President, Medical Affairs for Pain &amp; Neurology, and Vice President, Worldwide Development for Pain &amp; Inflammation, Oncology, and Diversified Products. During this period, she developed an interest in the ethics of drug development, and subsequently earned a Master of Bioethics degree from the University of Pennsylvania School of Medicine.</p>
<p>After joining Einstein/Montefiore in 2008 as Director of Bioethics Education and attending rheumatologist, Dr. Kitsis assumed an administrative role in the Department of Medicine (DOM) in 2014. As Vice Chair for Faculty Affairs and Professionalism, Dr. Kitsis was responsible for the appointment, promotion and credentialing of the DOM faculty. She spearheaded the development of the DOM Strategic Plan and led the creation of the DOM Physician Awards program, Faculty Scholars program, well-being initiative, annual reviews, and GRANDMED speaker program. She also co-founded the DOM Mentoring Program.&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>Kitsis EA. Rx for the pharmaceutical industry: call your doctors. <em>Hastings Ctr Rep</em>, 2009. 39: 18-21.</p>
<p>Kitsis EA. Physicians and the pharmaceutical industry: working together on conflict of interest. <em>Am J Bioeth</em>, 2011, 11: 51-52.</p>
<p>Kitsis EA. Shining a light on shadowing. <em>JAMA</em>, 2011. 305: 1029-1030.</p>
<p>Kitsis EA. Goldsammler M. Physician Shadowing: A review of the literature and proposal for guidelines.<em> Acad Med</em>, 2013, 88:102-10.</p>
<p>MacKenzie CR, Melzer M, Kitsis EA, CA Mancuso. Ethical challenges in rheumatology. <em>Arthritis Rheum</em>, 2013, July (Epub ahead of print).15.</p>
<p>Kitsis EA, Napier F, Juthani,V, Geyer, HL. Association of Sj&ouml;gren&rsquo;s syndrome with myotonic dystrophy type 1. BMJ Case Rep, 2019 Aug 28;12(8).</p>
<p>Wang J, Kitsis EA. Tangling the web: deception in online research. Am J Bioeth, 2013. 13:59-61.</p>
<p>Kitsis EA, Milan FB, Cohen HW. Who&rsquo;s misbehaving? Perceptions of unprofessional social media use by medical students and faculty. BMC Med Educ, 2016. 16:67.</p>
<p>Kitsis EA, Fleischman AR. If you see something, say something. JAMA Neurol, 2019. &nbsp;76(5):519-520.</p>
<p>Kitsis EA. Role synergy versus role conflict in dual-role consent in usual care trials. Am J Bioeth, 2019, 19: 42-43.Kitsis EA, Napier F, Juthani,V, Geyer, HL. Association of Sj&ouml;gren&rsquo;s syndrome with myotonic dystrophy type 1. BMJ Case Rep, 2019 Aug 28;12(8).</p>
<p>Keller MJ, Kitsis EA, Arora S, Chen J-T, Agarwal S, Ross MJ, Tomer Y, Southern W. Effect of systemic glucocorticoids on mortality or mechanical ventilation in patients with COVID-19. J Hosp Med, 2020. 15(8):489-493.</p>
<p>Ayesha B, Kumthekar A, Jain R, Patel S, Ramesh M, Ferastraoaru DE, Hudes G, Karagic M, Zafar S, Bartash R, Vasquez-Canizares N, Kitsis E, Tagoe C, Wahezi DM, Rubinstein T, Broder A. Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force. ACR Open Rheumatol. 2021 Mar;3(3):133-137.</p>
<p>Tomer Y, Gong M, Keller M, Southern W, Kitsis E, Kajita G, Shapiro L, Jariwala SP, Epstein E. Teamwork and leadership under fire at the epicenter of the Covid-19 epidemic in the Bronx. Frontiers in Medicine Frontiers in Medicine, 2021.</p>

EMR ID

5235

Is Open Scheduling

On

Harold D. Keiser

https://assets.montefioreeinstein.org/profiles/images/physphoto/Keiser_Harold_D_MD_3821.jpg

First Name

Harold

Last Name

Keiser

NPI

1245320951

Faculty ID

4585

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Titles

Locations

Education and Trainings

Professional Interests

<p>In years of clinical practice Dr. Harold Keiser has acquired experience over the broad range of problems referred to rheumatologists. Dr. Keiser takes special interest in the diagnosis and management of connective tissue disorders, gout, and the spondyloarthropathies.</p>

Research Profile

CHAM Provider

Off

Professional Title

EMR ID

3340

Visit Type ID

2528

Is Open Scheduling

On

Beverly K. Johnson

https://assets.montefioreeinstein.org/profiles/images/14112-beverly-johnson.jpg

First Name

Beverly

Last Name

Johnson

NPI

1336306992

Faculty ID

14112

CMO Specialties

Employment Status

Voluntary

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Johnson is the Chief of Rheumatology at Jacobi and North Central Bronx Hospitals.&nbsp; She graduated from Brown University with an A.B. in Religious Studies in 2001, and MD in 2006.&nbsp; She has a masters in epidemiology from Columbia Mailman School of Public Health in 2013.&nbsp; She runs the musculoskeletal ultrasound program for the Einstein rheumatology fellows, and runs a weekly ultrasound clinic at Jacobi.&nbsp; Dr. Johnson runs the&nbsp; Lupus Center at Jacobi, and is actively running lupus clinical trials. She also has run several quality improvement projects&nbsp; including one about the improving the quality of care of rheuamatoid arthritis in an underserved community which resulted in our hospital being selected as a model of excellence for RA care.&nbsp; Dr. Johnson speaks Spanish and is dedicated to provided high quality care in an underserved area.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Selected Publications

<h1>BIBLIOGRAPHY</h1>
<p class="MsoNormal" style="text-indent: -.25in; mso-list: l1 level1 lfo1; margin: 0in 0in .0001pt .25in;"><!-- [if !supportLists]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 12.0pt;"><span style="mso-list: Ignore;">A.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span></strong><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 12.0pt;">Original Communications in Reviewed Journals</span></strong></p>
<p class="MsoNormal" style="text-indent: -.25in; mso-list: l0 level1 lfo2; tab-stops: list .25in; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 12.0pt;">Johnson BK</span></strong><span style="font-size: 12.0pt; mso-bidi-font-weight: bold;">, Santana V, Schupf N, et. al. The heritability of abstract reasoning in Caribbean Latinos with familial Alzheimer disease.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Dementia and Geriatric Cognitive Disorders</em>, 2007;24(6):411-7.</span></p>
<p class="MsoNormal" style="text-indent: -.25in; mso-list: l0 level1 lfo2; tab-stops: list .25in; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 12.0pt;">Johnson BK</span></strong><span style="font-size: 12.0pt;">, <span style="mso-bidi-font-weight: bold;">Goodman S, Alexiades M, Figgie M, Demmer R and Mandl L. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement. <em style="mso-bidi-font-style: normal;">The Journal of Rheumatology</em>, 2013, 40(5): 617-623.</span></span></p>
<p class="MsoNormal" style="text-indent: -.25in; mso-list: l0 level1 lfo2; tab-stops: list .25in; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 12.0pt;">Goodman S, Mandl L, Figgie M, <strong style="mso-bidi-font-weight: normal;">Johnson BK</strong>, Alexiades M, Ghomrawi H. The use of biologic DMARDs identifies rheumatoid arthritis patients with more optimistic expectations of total knee arthroplasty. <em style="mso-bidi-font-style: normal;">HSS Journal</em>, 2014, 10: 117-123.</span></p>
<p class="MsoNormal" style="text-indent: -.25in; mso-list: l0 level1 lfo2; tab-stops: list .25in; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 12.0pt;">LoVerde ZJ, Mandl LA, <strong style="mso-bidi-font-weight: normal;">Johnson BK</strong>, Figgie MP, Boettner F, Lee YY, Goodman SM.<span style="mso-spacerun: yes;">&nbsp; </span>Rheumatoid Arthritis Does Not Increase Risk of Short-term Adverse Events after Total Knee Arthroplasty: A Retrospective Case-control Study. <em style="mso-bidi-font-style: normal;"><span style="mso-bidi-font-weight: bold;">The Journal of Rheumatology</span></em><span style="mso-bidi-font-weight: bold;">, 2015, 42(7): 1123-30.</span></span></p>
<p class="MsoNormal" style="text-indent: -.25in; mso-list: l0 level1 lfo2; tab-stops: list .25in; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 12.0pt; color: black;">Kumthekar A, <strong style="mso-bidi-font-weight: normal;">Johnson BK.</strong></span> <span style="font-size: 12.0pt; color: black;">Polyarticular Severe Tophaceous Gout Secondary to Limited Medication Access. </span><em style="mso-bidi-font-style: normal;"><span style="font-size: 12.0pt; mso-bidi-font-weight: bold;">The Journal of Rheumatology</span></em><span style="font-size: 12.0pt; mso-bidi-font-weight: bold;">,</span><span style="font-size: 12.0pt; color: black; background: white;">&nbsp;2015, 42(8):1528-9.</span></p>
<p class="MsoNormal" style="text-indent: -.25in; mso-list: l0 level1 lfo2; tab-stops: list .25in; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 12.0pt;">Goodman SM, <strong style="mso-bidi-font-weight: normal;">Johnson BK</strong>, Zhang M, Huang WT, Zhu R, Figgie M, Alexiades M, Mandl LA. Patients with Rheumatoid Arthritis have Similar Excellent Outcomes after Total Knee Replacement Compared with Patients with Osteoarthritis. <em style="mso-bidi-font-style: normal;"><span style="mso-bidi-font-weight: bold;">The Journal of Rheumatology</span></em>., 2016 Jan;43(1):46-53.</span></p>
<p class="MsoNormal" style="text-indent: -.25in; mso-list: l0 level1 lfo2; tab-stops: list .25in; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt;"><span style="mso-list: Ignore;">7.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Goodman%20SM%5BAuthor%5D&amp;… style="font-size: 12.0pt; background: white;">Goodman SM</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Springer%20B%5BAuthor%5D&amp;… style="font-size: 12.0pt; background: white;">Springer B</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Guyatt%20G%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Guyatt G</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Abdel%20MP%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Abdel MP</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Dasa%20V%5BAuthor%5D&amp;caut… style="font-size: 12.0pt; background: white;">Dasa V</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=George%20M%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">George M</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Gewurz-Singer%20O%5BAuthor%5D… style="font-size: 12.0pt; background: white;">Gewurz-Singer O</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Giles%20JT%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Giles JT</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Johnson%20B%5BAuthor%5D&amp;c… style="mso-bidi-font-weight: normal;"><span style="font-size: 12.0pt; background: white;">Johnson B</span></strong></a><span class="MsoHyperlink"><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 12.0pt; background: white;">K</span></strong></span><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Lee%20S%5BAuthor%5D&amp;cauth… style="font-size: 12.0pt; background: white;">Lee S</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Mandl%20LA%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Mandl LA</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Mont%20MA%5BAuthor%5D&amp;cau… style="font-size: 12.0pt; background: white;">Mont MA</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Sculco%20P%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Sculco P</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Sporer%20S%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Sporer S</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Stryker%20L%5BAuthor%5D&amp;c… style="font-size: 12.0pt; background: white;">Stryker L</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Turgunbaev%20M%5BAuthor%5D&am… style="font-size: 12.0pt; background: white;">Turgunbaev M</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Brause%20B%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Brause B</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Chen%20AF%5BAuthor%5D&amp;cau… style="font-size: 12.0pt; background: white;">Chen AF</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Gililland%20J%5BAuthor%5D&amp… style="font-size: 12.0pt; background: white;">Gililland J</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Goodman%20M%5BAuthor%5D&amp;c… style="font-size: 12.0pt; background: white;">Goodman M</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Hurley-Rosenblatt%20A%5BAutho… style="font-size: 12.0pt; background: white;">Hurley-Rosenblatt A</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Kirou%20K%5BAuthor%5D&amp;cau… style="font-size: 12.0pt; background: white;">Kirou K</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Losina%20E%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Losina E</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=MacKenzie%20R%5BAuthor%5D&amp… style="font-size: 12.0pt; background: white;">MacKenzie R</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Michaud%20K%5BAuthor%5D&amp;c… style="font-size: 12.0pt; background: white;">Michaud K</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Mikuls%20T%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Mikuls T</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Russell%20L%5BAuthor%5D&amp;c… style="font-size: 12.0pt; background: white;">Russell L</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Sah%20A%5BAuthor%5D&amp;cauth… style="font-size: 12.0pt; background: white;">Sah A</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Miller%20AS%5BAuthor%5D&amp;c… style="font-size: 12.0pt; background: white;">Miller AS</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Singh%20JA%5BAuthor%5D&amp;ca… style="font-size: 12.0pt; background: white;">Singh JA</span></a><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">,&nbsp;</span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Yates%20A%5BAuthor%5D&amp;cau… style="font-size: 12.0pt; background: white;">Yates A</span></a><span class="MsoHyperlink"><span style="font-size: 12.0pt; background: white;">. </span></span><span style="font-size: 12.0pt;">2017 <span class="highlight">American</span> <span class="highlight">College</span> of <span class="highlight">Rheumatology/American</span> <span class="highlight">Association</span> of <span class="highlight">Hip</span> and <span class="highlight">Knee</span> <span class="highlight">Surgeon Guideline</span> for the <span class="highlight">Perioperative</span> <span class="highlight">Management</span> of Antirheumatic <span class="highlight">Medication</span> in <span class="highlight">Patients</span> with <span class="highlight">Rheumatic Diseases</span> <span class="highlight">Undergoing</span> <span class="highlight">Elective</span> <span class="highlight">Total</span> <span class="highlight">Hip</span> or <span class="highlight">Total Knee Arthroplasty</span>.</span> <em style="mso-bidi-font-style: normal;"><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">Arthritis and Rheumatology</span></em><span style="font-size: 12.0pt; color: black; mso-color-alt: windowtext; background: white;">, 2017, 69(8):1538-1551. </span></p>
<p class="MsoListParagraph" style="text-indent: -.25in; line-height: normal; mso-list: l0 level1 lfo2; tab-stops: list .25in; background: white; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: #333333;"><span style="mso-list: Ignore;">8.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: #222222;">Chokshi, B, D&rsquo;Agati, V, Bizzocchi, L, <strong>Johnson, BK</strong>, Mendez, B, Jim, B. Rare Disease Case Report: </span><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: #333333;">Haemophagocytic lymphohistiocytosis with collapsing lupus podocytopathy as an unusual manifestation of systemic lupus erythematosus with APOL1 double-risk alleles. <span class="highwire-cite-metadata-journal"><em><span style="background: white;">BMJ Case Reports CP&nbsp;</span></em></span><span class="highwire-cite-metadata-year"><span style="background: white;">2019;</span></span><span class="highwire-cite-metadata-volume"><span style="background: white;">12: </span></span><span class="highwire-cite-metadata-pages"><span style="background: white;">bcr-2018-227860</span></span></span></p>
<p class="MsoListParagraph" style="text-indent: -.25in; line-height: normal; mso-list: l0 level1 lfo2; tab-stops: list .25in; background: white; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: #222222;"><span style="mso-list: Ignore;">9.<span style="font: 7.0pt 'Times New Roman';">&nbsp; </span></span></span><!--[endif]--><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: #222222;">Sheth, T, Mena, O, <strong>Johnson BK</strong>.<span style="mso-spacerun: yes;">&nbsp; </span>Assessment of Patient Satisfaction, Functionality and Quality of Life After Ultrasound Guided Knee Intervention. <em>Clinical Rheumatology</em>, in press.</span></p>
<p class="MsoListParagraph" style="text-indent: -.25in; line-height: normal; mso-list: l0 level1 lfo2; tab-stops: list .25in; background: white; margin: 0in 0in 6.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: #222222;"><span style="mso-list: Ignore;">10.<span style="font: 7.0pt 'Times New Roman';">&nbsp; </span></span></span><!--[endif]--><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: #222222; background: white;">Mejias, M, Ramirez de Oleo, I, <strong>Johnson BK.</strong> Association of hydroxychloroquine use and hemolytic anemia in patients with low levels of Glucose-6-phosphate dehydrogenase (G6PD). <em>Journal of Clinical Rheumatology</em>, in press.</span></p>

EMR ID

5696

Is Open Scheduling

Off